Oramed Pharmaceuticals Inc. (ORMP.OB) to Present Findings on Oral Insulin to the American Diabetes Association
6/24/2013 6:42:23 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
JERUSALEM, June 21, 2013 /PRNewswire via COMTEX/ -- Oramed Pharmaceuticals Inc. (nasdaqcm:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it will be presenting its abstract titled, "Dose response to oral insulin capsules in fasting, healthy subjects," at the 73rd Scientific Sessions of the American Diabetes Association, on June 21st through 25th, 2013, in Chicago, Illinois, USA.
Help employers find you! Check out all the jobs and post your resume.